A Phase 1, Randomized, Open-Label, Single-Dose, 4-Way Crossover Study to Assess the Relative Bioavailability of Four 80 mg Febuxostat XR Formulations

Name: A Phase 1, Randomized, Open-Label, Single-Dose, 4-Way Crossover Study to Assess the Relative Bioavailability of Four 80 mg Febuxostat XR Formulations
Creator: Vivli
Published: 2019-03-06T21:14:28+08:00

DataCite Commons2025-12-03 更新2026-05-07 收录

药代动力学

缓释制剂优化

数据链接：

https://search.vivli.org/doiLanding/studies/00003347/isLanding 数据链接链接失效反馈

官方服务：

资源简介：

This study will assess the relative bioavailability, safety and tolerability following administration of 80 mg single oral doses of 4 febuxostat extended release (XR) formulations.

提供机构：

Vivli

创建时间：

2019-03-06